Gynecology Drugs Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Jan 2019| TMR1291A| Transparency

Report Highlights

Global Gynecology Drugs market: Overview

This report analyzes the current and future scenario of the global gynecology drugs market. High incidence and prevalence of gynecology diseases and rise in patient awareness are major drivers of the global market.

The global gynecology drugs market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on therapeutics, indication, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global gynecology drugs market.

Global Gynecology Drugs Market: Key Segments

The global gynecology drugs market has been segmented based on therapeutics, indication, distribution channel, and region. Furthermore, in terms of therapeutics, the market has been divided into hormonal therapy and non-hormonal therapy. The non-hormonal therapy segment is likely to account for a leading share of the global market during the forecast period owing to the effectiveness of the products, rise in adoption of these products, and new product development. Decreasing use of hormonal products due to the risk of breast cancer has boosted the demand for non-hormonal pharmaceutical products. In terms of indication, the global market has been classified into gynecology cancers, endometriosis, female infertility, menopausal disorder, gynecology infections, polycystic ovary syndrome, contraception (birth control), and others. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is estimated to expand at a significant CAGR during forecast period, owing to the ease of use of online pharmacies and a rise in the number of internet users. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Gynecology Drugs Market: Regional Outlook

In terms of region, the global gynecology drugs market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global gynecology drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players in the global gynecology drugs market are Eli Lilly and Company, Pfizer, Inc., Merck & Co., Inc, Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Allergan Plc, and Bayer AG.

The global gynecology drugs market has been segmented as given below:

Global Gynecology Drugs Market, by Therapeutics
Hormonal Therapy
Estrogen Therapy
Progestin Therapy
Combination Therapy
Thyroid Replacement Therapy
Parathyroid Hormone Therapy
Others
Non-hormonal Therapy
Anti-Infective Agents
Anti-neoplastic Agents
Anti-inflammatory Agents
Others
Global Gynecology Drugs Market, by Indication
Gynecology Cancers
Endometriosis
Female Infertility
Menopausal Disorder
Gynecology Infections
Polycystic Ovary Syndrome
Contraception (Birth Control)
Others
Global Gynecology Drugs Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gynecology Drugs Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Gynecology Drugs Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 2 : Global Gynecology Drugs Market Value (US$ Mn) Forecast, by Hormonal Therapy, 2016–2026
  • Table 3 : Global Gynecology Drugs Market Value (US$ Mn) Forecast, by Non-Hormonal Therapy, 2016–2026
  • Table 4 : Global Gynecology Drugs Market Value (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 5 : Global Gynecology Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 6 : Global Gynecology Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
  • Table 7 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, by Country, 2018–2026
  • Table 8 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 9 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, by Hormonal Therapy, 2016–2026
  • Table 10 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, by Non-Hormonal Therapy, 2016–2026
  • Table 11 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 12 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 13 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
  • Table 14 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 15 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, by Hormonal Therapy, 2016–2026
  • Table 16 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, by Non-Hormonal Therapy, 2016–2026
  • Table 17 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 18 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 19 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
  • Table 20 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 21 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, by Hormonal Therapy, 2016–2026
  • Table 22 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, by Non-hormonal Therapy, 2016–2026
  • Table 23 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 24 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 25 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
  • Table 26 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 27 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, by Hormonal Therapy, 2016–2026
  • Table 28 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, by Non-hormonal Therapy, 2016–2026
  • Table 29 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 30 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 31 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
  • Table 32 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
  • Table 33 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, by Hormonal Therapy, 2016–2026
  • Table 34 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, by Non-hormonal Therapy, 2016–2026
  • Table 35 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 36 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Global Gynecology Drugs Market Revenue Projection (US$ Mn), 2016–2026
  • Figure 2 : Global Gynecology Drugs Market Value Share, by Therapeutics, 2018
  • Figure 3 : Global Gynecology Drugs Market Value Share, by Indication, 2018
  • Figure 4 : Global Gynecology Drugs Market Value Share, by Region, 2018
  • Figure 5 : Global Gynecology Drugs Market Value Share, by Distribution Channel, 2018
  • Figure 6 : Global Gynecology Drugs Market Value Share Analysis, by Therapeutics, 2018 and 2026
  • Figure 7 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Hormonal Therapy, 2016–2026
  • Figure 8 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Non-Hormonal Therapy, 2016–2026
  • Figure 9 : Global Gynecology Drugs Market Attractiveness, by Therapeutics, 2018–2026
  • Figure 10 : Global Gynecology Drugs Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 11 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Gynecology Cancers, 2016–2026
  • Figure 12 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Endometriosis, 2016–2026
  • Figure 13 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Female Infertility, 2016–2026
  • Figure 14 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Menopausal Disorder, 2016–2026
  • Figure 15 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Gynecology Infections, 2016–2026
  • Figure 16 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Polycystic Ovary Syndrome, 2016–2026
  • Figure 17 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Contraception (Birth Control), 2016–2026
  • Figure 18 : Global Gynecology Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
  • Figure 19 : Global Gynecology Drugs Market Attractiveness, by Indication
  • Figure 20 : Global Gynecology Drugs Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 21 : Global Gynecology Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2016–2026
  • Figure 22 : Global Gynecology Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2016–2026
  • Figure 23 : Global Gynecology Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2016–2026
  • Figure 24 : Global Gynecology Drugs Market Attractiveness, by Distribution Channel
  • Figure 25 : Global Gynecology Drugs Market Value Share, by Region, 2018 and 2026
  • Figure 26 : Global Gynecology Drugs Market Attractiveness, by Region, 2018–2026
  • Figure 27 : North America Gynecology Drugs Market Value (US$ Mn) Forecast, 2018–2026
  • Figure 28 : North America Gynecology Drugs Market Attractiveness Analysis, by Country
  • Figure 29 : North America Gynecology Drugs Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 30 : North America Gynecology Drugs Market Value Share Analysis, by Therapeutics, 2018 and 2026
  • Figure 31 : North America Gynecology Drugs Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 32 : North America Gynecology Drugs Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 33 : North America Gynecology Drugs Market Attractiveness Analysis, by Therapeutics, 2018–2026
  • Figure 34 : North America Gynecology Drugs Market Attractiveness Analysis, by Indication, 2018–2026
  • Figure 35 : North America Gynecology Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 36 : Europe Gynecology Drugs Market Value (US$ Mn) Forecast, 2018–2026
  • Figure 37 : Europe Gynecology Drugs Market Attractiveness Analysis, by Country/Sub-region
  • Figure 38 : Europe Gynecology Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 39 : Europe Gynecology Drugs Market Value Share Analysis, by Therapeutics, 2018 and 2026
  • Figure 40 : Europe Gynecology Drugs Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 41 : Europe Gynecology Drugs Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 42 : Europe Gynecology Drugs Market Attractiveness Analysis, by Therapeutics, 2018–2026
  • Figure 43 : Europe Gynecology Drugs Market Attractiveness Analysis, by Indication, 2018–2026
  • Figure 44 : Europe Gynecology Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 45 : Asia Pacific Gynecology Drugs Market Value (US$ Mn) Forecast, 2018–2026
  • Figure 46 : Asia Pacific Gynecology Drugs Market Attractiveness Analysis, by Country/Sub-region
  • Figure 47 : Asia Pacific Gynecology Drugs Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 48 : Asia Pacific Gynecology Drugs Market Value Share Analysis, by Therapeutics, 2018 and 2026
  • Figure 49 : Asia Pacific Gynecology Drugs Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 50 : Asia Pacific Gynecology Drugs Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 51 : Asia Pacific Gynecology Drugs Market Attractiveness Analysis, by Therapeutics, 2018–2026
  • Figure 52 : Asia Pacific Gynecology Drugs Market Attractiveness Analysis, by Indication, 2018–2026
  • Figure 53 : Asia Pacific Gynecology Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 54 : Latin America Gynecology Drugs Market Value (US$ Mn) Forecast, 2018–2026
  • Figure 55 : Latin America Gynecology Drugs Market Attractiveness Analysis, by Country/Sub-region
  • Figure 56 : Latin America Gynecology Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 57 : Latin America Gynecology Drugs Market Value Share Analysis, by Therapeutics, 2018 and 2026
  • Figure 58 : Latin America Gynecology Drugs Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 59 : Latin America Gynecology Drugs Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 60 : Latin America Gynecology Drugs Market Attractiveness Analysis, by Therapeutics, 2018–2026
  • Figure 61 : Latin America Gynecology Drugs Market Attractiveness Analysis, by Indication, 2018–2026
  • Figure 62 : Latin America Gynecology Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 63 : Middle East & Africa Gynecology Drugs Market Value (US$ Mn) Forecast, 2018–2026
  • Figure 64 : Middle East & Africa Gynecology Drugs Market Attractiveness Analysis, by Country/Sub-region
  • Figure 65 : Middle East & Africa Gynecology Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 66 : Middle East & Africa Gynecology Drugs Market Value Share Analysis, by Therapeutics, 2018 and 2026
  • Figure 67 : Middle East & Africa Gynecology Drugs Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 68 : Middle East & Africa Gynecology Drugs Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 69 : Middle East & Africa Gynecology Drugs Market Attractiveness Analysis, by Therapeutics, 2018–2026
  • Figure 70 : Middle East & Africa Gynecology Drugs Market Attractiveness Analysis, by Indication, 2018–2026
  • Figure 71 : Middle East & Africa Gynecology Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 72 : Global Gynecology Drugs Market Share Analysis, by Company, 2017 (Estimated)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS